OR5C1
gene geneOn this page
Also known as OR9-FhRPK-465_F_21
Summary
OR5C1 (olfactory receptor family 5 subfamily C member 1, HGNC:8331) is a protein-coding gene on chromosome 9q33.2, encoding Olfactory receptor 5C1 (Q8NGR4). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 392391 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 64 total
- MANE Select transcript:
NM_001001923
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8331 |
| Approved symbol | OR5C1 |
| Name | olfactory receptor family 5 subfamily C member 1 |
| Location | 9q33.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OR9-F, hRPK-465_F_21 |
| Ensembl gene | ENSG00000148215 |
| Ensembl biotype | protein_coding |
| Entrez | 392391 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000373680
RefSeq mRNA: 1 — MANE Select: NM_001001923
NM_001001923
CCDS: CCDS35131
Canonical transcript exons
ENST00000373680 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001461215 | 122788933 | 122789895 |
Expression profiles
Bgee: expression breadth tissue_specific, 1 present calls, max score 55.90.
FANTOM5 (CAGE): breadth broad, TPM avg 0.3720 / max 10.9284, expressed in 192 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 205610 | 0.3720 | 192 |
Top tissues by expression
116 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 55.90 | silver quality |
| colonic epithelium | UBERON:0000397 | 45.91 | gold quality |
| calcaneal tendon | UBERON:0003701 | 43.07 | gold quality |
| bone marrow cell | CL:0002092 | 42.54 | gold quality |
| tonsil | UBERON:0002372 | 41.28 | gold quality |
| stromal cell of endometrium | CL:0002255 | 40.11 | gold quality |
| apex of heart | UBERON:0002098 | 37.93 | silver quality |
| granulocyte | CL:0000094 | 37.53 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 36.86 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| bone marrow | UBERON:0002371 | 35.00 | gold quality |
| corpus callosum | UBERON:0002336 | 34.93 | gold quality |
| muscle tissue | UBERON:0002385 | 33.62 | gold quality |
| urinary bladder | UBERON:0001255 | 32.83 | gold quality |
| liver | UBERON:0002107 | 32.19 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 30.44 | gold quality |
| blood | UBERON:0000178 | 29.40 | gold quality |
| lymph node | UBERON:0000029 | 28.96 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| leukocyte | CL:0000738 | 28.05 | gold quality |
| adrenal tissue | UBERON:0018303 | 27.77 | gold quality |
| primary visual cortex | UBERON:0002436 | 27.74 | gold quality |
| right coronary artery | UBERON:0001625 | 27.60 | gold quality |
| monocyte | CL:0000576 | 27.45 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.96 | gold quality |
| endometrium | UBERON:0001295 | 26.57 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.32 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or5c1 | ENSMUSG00000049018 |
| rattus_norvegicus | Or5c1 | ENSRNOG00000008003 |
Paralogs (96): OR5F1 (ENSG00000149133), OR8K1 (ENSG00000150261), OR5M9 (ENSG00000150269), OR14K1 (ENSG00000153230), OR8J3 (ENSG00000167822), OR5I1 (ENSG00000167825), OR5AU1 (ENSG00000169327), OR9K2 (ENSG00000170605), OR8B12 (ENSG00000170953), OR10H3 (ENSG00000171936), OR8I2 (ENSG00000172154), OR8U1 (ENSG00000172199), OR10V1 (ENSG00000172289), OR5A1 (ENSG00000172320), OR5A2 (ENSG00000172324), OR5B12 (ENSG00000172362), OR5B2 (ENSG00000172365), OR9I1 (ENSG00000172377), OR9G4 (ENSG00000172457), OR5AR1 (ENSG00000172459), OR5AP2 (ENSG00000172464), OR8J1 (ENSG00000172487), OR5B3 (ENSG00000172769), OR10W1 (ENSG00000172772), OR5M3 (ENSG00000174937), OR5J2 (ENSG00000174957), OR10H4 (ENSG00000176231), OR5AN1 (ENSG00000176495), OR14C36 (ENSG00000177174), OR6B3 (ENSG00000178586), OR10Q1 (ENSG00000180475), OR8G2P (ENSG00000181214), OR5AK2 (ENSG00000181273), OR5AK3P (ENSG00000181282), OR5M8 (ENSG00000181371), OR8D4 (ENSG00000181518), OR8H1 (ENSG00000181693), OR8K5 (ENSG00000181752), OR8H3 (ENSG00000181761), OR8H2 (ENSG00000181767)
Protein
Protein identifiers
Olfactory receptor 5C1 — Q8NGR4 (reviewed: Q8NGR4)
Alternative names: Olfactory receptor 5C2, Olfactory receptor 9-F
All UniProt accessions (2): Q8NGR4, A0A126GW42
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001001923* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (18 total): topological domain 8, transmembrane region 7, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NGR4-F1 | 86.94 | 0.59 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 101–193
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 17 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_ODORANT_BINDING, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, REACTOME_OLFACTORY_SIGNALING_PATHWAY, REACTOME_SENSORY_PERCEPTION, GOBP_DETECTION_OF_CHEMICAL_STIMULUS, GOMF_MOLECULAR_TRANSDUCER_ACTIVITY
GO Biological Process (4): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), odorant binding (GO:0005549)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
168 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR5C1 | C1orf167 | Q5SNV9 | 692 |
| OR5C1 | KIAA0825 | Q8IV33 | 648 |
| OR5C1 | PRSS54 | Q6PEW0 | 598 |
| OR5C1 | KRTAP12-3 | P60328 | 597 |
| OR5C1 | TMEM235 | A6NFC5 | 542 |
| OR5C1 | GPR25 | O00155 | 460 |
| OR5C1 | C1QTNF8 | P60827 | 447 |
| OR5C1 | MRGPRF | Q96AM1 | 440 |
| OR5C1 | TAC4 | Q86UU9 | 428 |
| OR5C1 | DLL1 | O00548 | 413 |
| OR5C1 | DDI1 | Q8WTU0 | 412 |
| OR5C1 | SPATA31D3 | P0C874 | 403 |
| OR5C1 | ALPK3 | Q96L96 | 390 |
| OR5C1 | SPATA31D4 | Q6ZUB0 | 365 |
| OR5C1 | LHFPL6 | Q9Y693 | 357 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR52B2 | PCCA | psi-mi:“MI:0914”(association) | 0.350 |
| OR5C1 | PTX3 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (5): OR5C1 (Affinity Capture-MS), CCPG1 (Affinity Capture-MS), PTX3 (Affinity Capture-MS), BLK (Affinity Capture-MS), FAM81A (Affinity Capture-MS)
ESM2 similar proteins: A6NH00, O60403, O95371, O95918, P23266, P23267, P23275, P34984, P47881, P47888, P47893, Q15619, Q5JQS5, Q5TZ20, Q60885, Q60891, Q60894, Q6IEZ7, Q7Z3T1, Q8N628, Q8NG76, Q8NG77, Q8NG97, Q8NGA6, Q8NGC4, Q8NGE3, Q8NGE9, Q8NGQ2, Q8NGQ4, Q8NGR4, Q8NGS0, Q8NGT9, Q8NGX9, Q8NGY1, Q8NGZ6, Q8NH02, Q8NH03, Q8NH04, Q8NHB1, Q8VGD6
Diamond homologs: A6NL26, O95221, P0C617, P0C626, P0C7N1, P0C7N5, P0C7N8, P0DMU2, P37068, P37070, P37071, P37072, Q13606, Q15617, Q15620, Q60880, Q60882, Q60886, Q60893, Q60894, Q60895, Q6IEU7, Q6UXT6, Q7TR96, Q8N0Y5, Q8N127, Q8N146, Q8N162, Q8NG75, Q8NGC0, Q8NGE9, Q8NGF4, Q8NGF7, Q8NGG0, Q8NGG1, Q8NGG2, Q8NGG3, Q8NGG4, Q8NGG5, Q8NGG8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
64 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 59 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
228 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:122789348:C:G | donor_gain | 0.7400 |
| 9:122789241:CCAGA:C | acceptor_gain | 0.6500 |
| 9:122789240:TCCAG:T | acceptor_gain | 0.6300 |
| 9:122789783:T:TA | acceptor_gain | 0.6300 |
| 9:122789830:G:GT | donor_gain | 0.6200 |
| 9:122789779:ACCCT:A | acceptor_gain | 0.6100 |
| 9:122789553:T:TA | acceptor_gain | 0.6000 |
| 9:122789739:C:G | donor_gain | 0.6000 |
| 9:122789577:GTT:G | donor_gain | 0.5900 |
| 9:122789575:GT:G | donor_gain | 0.5800 |
| 9:122789117:C:G | donor_gain | 0.5600 |
| 9:122789243:AGATG:A | acceptor_gain | 0.5500 |
| 9:122789694:GAT:G | donor_gain | 0.5500 |
| 9:122789242:CAG:C | acceptor_gain | 0.5400 |
| 9:122789668:G:GA | donor_gain | 0.5400 |
| 9:122789697:G:GG | donor_gain | 0.5400 |
| 9:122789574:GGT:G | donor_gain | 0.5300 |
| 9:122789575:GTG:G | donor_gain | 0.5300 |
| 9:122789576:TGT:T | donor_gain | 0.5300 |
| 9:122789578:T:TG | donor_gain | 0.5300 |
| 9:122789650:C:T | donor_gain | 0.5300 |
| 9:122789667:T:TA | donor_gain | 0.5200 |
| 9:122789717:T:G | acceptor_gain | 0.5200 |
| 9:122789579:T:A | donor_gain | 0.5100 |
| 9:122789117:C:CG | donor_gain | 0.5000 |
| 9:122789398:GGGGC:G | donor_gain | 0.4900 |
| 9:122789669:G:GG | donor_gain | 0.4900 |
| 9:122789722:C:G | donor_gain | 0.4900 |
| 9:122789642:G:T | donor_gain | 0.4800 |
| 9:122789132:T:TA | acceptor_gain | 0.4700 |
AlphaMissense
2059 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:122788978:T:C | F16L | 0.925 |
| 9:122788980:C:A | F16L | 0.925 |
| 9:122788980:C:G | F16L | 0.925 |
| 9:122789446:T:C | F172L | 0.916 |
| 9:122789448:C:A | F172L | 0.916 |
| 9:122789448:C:G | F172L | 0.916 |
| 9:122789473:T:C | F181L | 0.907 |
| 9:122789475:C:A | F181L | 0.907 |
| 9:122789475:C:G | F181L | 0.907 |
| 9:122789434:T:C | F168L | 0.901 |
| 9:122789436:C:A | F168L | 0.901 |
| 9:122789436:C:G | F168L | 0.901 |
| 9:122789254:T:C | F108L | 0.879 |
| 9:122789256:T:A | F108L | 0.879 |
| 9:122789256:T:G | F108L | 0.879 |
| 9:122789056:A:C | S42R | 0.843 |
| 9:122789058:C:A | S42R | 0.843 |
| 9:122789058:C:G | S42R | 0.843 |
| 9:122789476:T:C | F182L | 0.843 |
| 9:122789478:C:A | F182L | 0.843 |
| 9:122789478:C:G | F182L | 0.843 |
| 9:122789713:T:C | F261L | 0.837 |
| 9:122789715:C:A | F261L | 0.837 |
| 9:122789715:C:G | F261L | 0.837 |
| 9:122789815:A:C | S295R | 0.810 |
| 9:122789817:C:A | S295R | 0.810 |
| 9:122789817:C:G | S295R | 0.810 |
| 9:122789773:T:C | F281L | 0.804 |
| 9:122789775:C:A | F281L | 0.804 |
| 9:122789775:C:G | F281L | 0.804 |
dbSNP variants (sampled 300 via entrez): RS1000008912 (9:122788517 G>T), RS1001819480 (9:122788447 C>A), RS1003861514 (9:122787681 G>A,C), RS1003944152 (9:122787117 GA>G,GAA), RS1004392931 (9:122789974 G>A), RS1006065784 (9:122789113 A>G), RS1006612464 (9:122789211 A>G), RS1007207882 (9:122790199 T>C,G), RS1007736306 (9:122787644 CA>C), RS10115857 (9:122787689 T>A), RS1013480945 (9:122788759 G>C), RS1014256939 (9:122789484 T>C), RS1014437153 (9:122789706 A>G), RS1014542344 (9:122787703 G>A), RS1014672582 (9:122789726 GCC>G,GC)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Particulate Matter | increases abundance, decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.